Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis

被引:5
|
作者
Oh, Ju Hyun [1 ]
Kang, Jieun [2 ]
Song, Jin Woo [3 ]
机构
[1] Inje Univ, Sanggye Paik Hosp, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea
[2] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Coll Med, Goyang Si, Gyeonggi Do, South Korea
[3] Univ Ulsan, Asan Med Ctr, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
hypersensitivity pneumonitis; mortality; prognosis; fibrosis; high-resolution computed tomography; IDIOPATHIC PULMONARY-FIBROSIS; FLEISCHNER-SOCIETY; CT FINDINGS; SURVIVAL; LUNG; STANDARDIZATION; PROGNOSIS; INDEXES;
D O I
10.3389/fmed.2023.1131070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundVariable clinical courses make it challenging to predict mortality resulting from fibrotic hypersensitivity pneumonitis (HP). This study evaluated the usefulness of radiologic parameters for predicting mortality in patients with fibrotic HP. MethodsClinical data and high-resolution computed tomography (HRCT) images, which were scored for reticulation, honeycombing, ground glass opacity (GGO), consolidation, and mosaic attenuation (MA) by visual assessment, were retrospectively analyzed in a total of 101 patients with fibrotic HP (all biopsy-proven cases). Fibrosis score was defined as the sum of reticulation and honeycombing scores. ResultsThe mean age of the 101 patients was 58.9 years, and 60.4% were females. During the follow-up (median: 55.5 months; interquartile range: 37.7-89.0 months), the 1-, 3-and 5-year mortality rates were 3.9, 16.8, and 32.7%, respectively. The non-survivors were older and had significantly lower lung function and minimum oxygen saturation during the 6-min walk test than the survivors. The non-survivors had higher scores of reticulation, honeycombing, GGO, fibrosis, and MA on HRCT than survivors. In the multivariable Cox analysis, reticulation, GGO, and fibrosis scores were independent prognostic factors for mortality in patients with fibrotic HP, as well as age. Fibrosis score showed great performance for predicting the 5-year mortality (AUC = 0.752, p < 0.001) and higher mortality was recorded for patients with high fibrosis score (>= 12.0%) (the mean survival time: 58.3 vs. 146.7 months, p < 0.01) than those without. ConclusionOur results suggest that radiologic fibrosis score may be a useful predictor of mortality in patients with fibrotic HP.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    Fujimoto, Hajime
    Yasuma, Taro
    D'Alessandro-Gabazza, Corina N.
    Gabazza, Esteban C.
    Hataji, Osamu
    Kobayashi, Tetsu
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (01)
  • [42] CLINICAL MODIFIERS TO IMMUNOSUPPRESSION RESPONSE IN FIBROTIC HYPERSENSITIVITY PNEUMONITIS
    Kypreos, Margaret
    Adams, Traci
    De Boer, Esther
    Batra, Kiran
    Glazer, Craig
    Newton, Chad
    [J]. CHEST, 2020, 158 (04) : 1838A - 1838A
  • [43] Spontaneous Pneumomediastinum in a Patient With Chronic Fibrotic Hypersensitivity Pneumonitis
    Azar, M.
    Onofrei, C. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [44] Pirfenidone in fibrotic hypersensitivity pneumonitis: is it ready for prime time?
    Assayag, Deborah
    Chaudhuri, Nazia
    [J]. THORAX, 2023, 78 (11) : 1059 - 1060
  • [45] Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis
    De Sadeleer, Laurens J.
    McDonough, John E.
    Schupp, Jonas C.
    Yan, Xiting
    Vanstapel, Arno
    Van Herck, Anke
    Everaerts, Stephanie
    Geudens, Vincent
    Sacreas, Annelore
    Goos, Tinne
    Aelbrecht, Celine
    Nawrot, Tim S.
    Martens, Dries S.
    Schols, Dominique
    Claes, Sandra
    Verschakelen, Johny A.
    Verbeken, Eric K.
    Ackermann, Maximilian
    Decottignies, Anabelle
    Mahieu, Manon
    Hackett, Tillie-Louise
    Hogg, James C.
    Vanaudenaerde, Bart M.
    Verleden, Stijn E.
    Kaminski, Naftali
    Wuyts, Wim A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (01) : 60 - +
  • [46] Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis
    Nishida, Takashi
    Kawate, Eriko
    Ishiguro, Takashi
    Kanauchi, Tetsu
    Shimizu, Yoshihiko
    Takayanagi, Noboru
    [J]. ERJ OPEN RESEARCH, 2022, 8 (01)
  • [47] Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management
    Kouranos, Vasileios
    Jacob, Joseph
    Nicholson, Andrew
    Renzoni, Elisabetta
    [J]. JOURNAL OF CLINICAL MEDICINE, 2017, 6 (06)
  • [48] Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis
    Gimenez, Andrea
    Storrer, Karin
    Kuranishi, Lilian
    Soares, Maria Raquel
    Ferreira, Rimarcs Gomes
    Pereira, Carlos A. C.
    [J]. THORAX, 2018, 73 (04) : 391 - 392
  • [49] Transbronchial lung cryobiopsy for the diagnosis of Fibrotic Hypersensitivity Pneumonitis
    Ferreira, Pedro Magalhaes
    Machado, Francisco
    Novais-Bastos, Helder
    Melo, Natalia
    Alexandre, Andre Terras
    Mota, Patricia Caetano
    Guimaraes, Susana
    Souto-Moura, Conceicao
    Carvalho, Andre
    Morais, Antonio
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [50] Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
    Sumikawa, Hiromitsu
    Komiya, Kosaku
    Egashira, Ryoko
    Tominaga, Junya
    Ueno, Midori
    Fukuda, Taiki
    Yamada, Daisuke
    Takei, Reoto
    Kataoka, Kensuke
    Kimura, Tomoki
    Kondoh, Yasuhiro
    Ejima, Masaru
    Shimamura, Takashi
    Tateishi, Tomoya
    Tomioka, Hiromi
    Miyazaki, Yasunari
    Suda, Takafumi
    Johkoh, Takeshi
    [J]. RESPIRATORY INVESTIGATION, 2024, 62 (05) : 798 - 803